medigraphic.com
ISSN 1561-3046 (Electronic)

2018, Number 1

<< Back Next >>

Rev Cub Med Mil 2018; 47 (1)

Markers of kidney damage in surgical single-kidney patients

de Armas GT, Capote PL, Castañer MJB, Herrera OY

Language: Spanish
References: 21
Page: 50-57
PDF size: 232.71 Kb.


ABSTRACT

Introduction: the importance of renal damage markers to assess the evolution and prognosis of patients with kidney diseases is known.
Objective: to identify the presence of markers of renal damage in surgical singlekidney patients and to relate them to the burden of comorbidities.
Methods: cross-sectional study in 88 patients treated at the CMH "Dr. Luis Díaz Soto". The variables were microalbuminuria, proteinuria and the burden of comorbidities. The Odd Ratio (OR) and the Chi squared for the qualitative variables and the standard deviation (SD) and the Student t for the quantitative ones were determined. Significant p≤ 0.05 was considered significant, with 95 % reliability.
Results: there was an increase in the presence of markers of kidney damage after nephrectomy, microalbuminuria from 17 to 35 patients (p= 0,004 and OR: 2.7), proteinuria from 12 to 33 (p= 0,005 and OR: 3.8). The higher the load of comorbidities, the greater the presence of renal damage markers [X2= 19.48; p= 0.000 and OR: 3 (1.19-7.55)].
Conclusions: nephrectomy leads to an increase in the presence of markers of kidney damage at 2 years of follow-up, mainly in patients with the highest number of comorbidities.


REFERENCES

  1. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol. 1989;135:719-33.

  2. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int. 1990;38:384-94.

  3. Praga M, Andrés A, Hernández E, Montoyo C, Mazuecos A, Campo C, et al. Tubular dysfunction in nephrotic syndrome: incidence and prognostic implications. Nephrol Dial Transplant. 1991;6:683-8.

  4. Foster MH, Sant GR, Donohoe JF, Harrington JT. Prolonged survival with a remnant kidney. Am J Kindey Dis. 1991;17:261-5.

  5. Kiprov DD, Colvin RB, McCluskey AB. Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest. 1982;46:275- 81.

  6. Argueso LR, Ritchey ML, Boyle ET, Milliner DS, Bergstralh EJ, Kramer SA. Prognosis of patients with unilateral renal agenesis. Pediatr Nephrol. 1992;6:412-6.

  7. Murillo-Brambila D, Núñez-Gómez FE, González-Sanchidrián S, Mucillo-Bermejo M, Sharma A, Ronco C. Utilidad clínica de la reserva funcional renal. Diálisis y Trasplante. 2015;36(1):27-33.

  8. García-Salcido Francisco J, Santana-Rios Z, Urdiales-Ortiz A, Fulda-Graue S. Insuficiencia renal crónica en pacientes nefrectomizados por cáncer renal, frecuencia y factores asociados. Rev Mex Urol. 2012;72(1):3-7.

  9. Najarian JS, Chavers BM, McHugh LG, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet. 1992;340:807-810.

  10. Watnick TJ, Jenkins RR, Rackoff P, Baumgarten A, Bia MJ. Microalbuminuria and hypertension in long-term renal donors. Transplantation. 1997;45:59-65.

  11. Riehl J, Schmitt H, Bongartz D, Bergmann D, Sieberth HG. Long-term follow-up of kidney donors: a longitudinal study. Nephrol Dial Transplant. 1997;12:1615-21.

  12. Simeone M, Armeni A, Summaria Ch, Cerantonio A, Fuiano G. Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney. Renal Failure. 2017;39(1):660-70.

  13. Juan García I, Puchades MJ, Solís MA, Pascual B, Torregrosa I, Ramos C, et al. Evolución de la función renal y factores de progresión en pacientes nefrectomizados. Nefrología. 2010;30(2):202-7.

  14. Villareal Giraldo AE, Ferrándiz Espadin RA, Salinas Cier CE. Evaluación de la función renal a largo plazo en niños monorrenos en un hospital nacional. Repositorio Institucional Universidad Peruana Cayetano Heredia. 2017.

  15. Garg AX. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int. 2006;70:1801- 10.

  16. Rizvi SA, Naqvi SA, Jawad F, Ahmed E, Asghar A, Zafar MN, et al. Living kidney donor follow-up in a dedicated clinic. Transplantation. 2005;79:1247-51.

  17. Carrasco J, Avillo V, Iglesias T, Kerkebe M. Nefrectomía parcial laparoscópica. Evaluación de sus efectos sobre la función renal. Rev Urol. 2015;46-9.

  18. García Velazques DP, Vanegas Ponce H, Gómez de Ossio MD. Función renal y proteinuria en donadores antes y después de la nefrectomía. Rev Mex Trasp. 2017;6(1):12-7.

  19. Dorado E, Muesca MV, Khoury M, Barreiro D, Lafós N, Rausch S. Relación entre gravedad de ateroesclerosis y progresión de enfermedad renal en pacientes nefrectomizados. Medicina (Buenos Aires). 2017;77:95-9.

  20. De la Cruz Cárdenas D. Evolución de la función renal postnefrectomía del donador vivo con criterios expandidos al año, en comparación con el donador vivo ideal en la unidad médica de alta especialidad. Instituto Mexicano del Seguro Social. Delegación Veracruz Norte. Unidad Médica de alta especialidad, H. E. Centro Médico Nacional Adolfo Ruiz Cortines. Veracruz, 2014.

  21. Gang LI, Yun-Peng W, Lu-Lin MA, Jing Z, Hong-Xian Z, Yi H, et al. Merginal living donor in kidney transplantation: experience in a Chinese single center. Chin Med J. 2013;126(15):2810-4.




2020     |     www.medigraphic.com